Merck & Co., Inc. is a global health care company that delivers innovative health solutions through its prescription medicines, vaccines, biologic therapies, and animal health products. The company actively monitors the business development landscape for growth opportunities that meet its strategic criteria, indicating a focus on resource allocation and investment decisions that align with its business strategies. Merck's operations are managed on a product basis, encompassing both pharmaceutical and animal health segments, which highlights the integration of technology capabilities in supporting business needs and enhancing operational efficiency. The company has made significant investments in its research and development pipeline, reflecting its commitment to business innovation and the development of strategic resources that can drive performance gains. In 2020, Merck's capital allocation priorities included completing business development transactions and investing in its pipeline, which underscores the importance of IT resources and capabilities in transforming the firm into a competitive force. The company also emphasizes the significance of mobilizing and deploying IT-based resources in combination with other capabilities to leverage business value and enhance organizational effectiveness. Merck's digital transformation initiatives include an extensive suite of digitally connected identification, traceability, and monitoring products within its animal health segment, which illustrates the integration of digital technologies into its operational framework. The company’s strategic collaborations and acquisitions, such as those with Seagen and Velosbio, further demonstrate its focus on enhancing its technology portfolio and capabilities in response to evolving market dynamics. Merck's commitment to operational flexibility is evident in its approach to managing the impacts of external influences, such as the COVID-19 pandemic, which necessitated adjustments in its operational strategies and resource deployment. The company's ability to adapt to changing business environments and consumer demands is indicative of its organizational agility and capability to respond to market restructuring. Additionally, Merck's focus on information management capability ensures that it can provide data and information to users with appropriate levels of accuracy, timeliness, and reliability, which is crucial for informed decision-making and strategic alignment. The firm’s investments in IT infrastructure and governance practices are essential for supporting its operational processes and enhancing its competitive positioning in the market. Overall, Merck's strategic resource allocation and investment choices reflect a comprehensive understanding of the interplay between technology capabilities and business performance, positioning the company to capitalize on emerging opportunities and navigate challenges within the healthcare landscape.